Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONCE

Spark Therapeutics (ONCE) Stock Price, News & Analysis

Spark Therapeutics logo

About Spark Therapeutics Stock (NASDAQ:ONCE)

Advanced Chart

Key Stats

Today's Range
$0.18
$0.18
50-Day Range
$110.05
$113.57
52-Week Range
$34.53
$114.20
Volume
N/A
Average Volume
891,560 shs
Market Capitalization
$6.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spark Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ONCE Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

ONCE Stock Analysis - Frequently Asked Questions

Spark Therapeutics Inc (NASDAQ:ONCE) released its quarterly earnings results on Tuesday, August, 7th. The biotechnology company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.43) by $0.34. The biotechnology company had revenue of $25.19 million for the quarter, compared to the consensus estimate of $29.44 million. Spark Therapeutics had a negative trailing twelve-month return on equity of 59.10% and a negative net margin of 358.41%.

Spark Therapeutics (ONCE) raised $88 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 5,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Credit Suisse acted as the underwriters for the IPO and Cowen and Company and Sanford C. Bernstein were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spark Therapeutics investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Brainstorm Cell Therapeutics (BCLI), Meta Platforms (META), Alibaba Group (BABA), Gilead Sciences (GILD) and Micron Technology (MU).

Company Calendar

Last Earnings
8/07/2018
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ONCE
CIK
1609351
Fax
N/A
Employees
368
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$78.82 million
Net Margins
-358.41%
Pretax Margin
N/A
Return on Equity
-59.10%
Return on Assets
-33.13%

Debt

Debt-to-Equity Ratio
0.35
Current Ratio
4.67
Quick Ratio
4.35

Sales & Book Value

Annual Sales
$64.72 million
Price / Sales
0.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$13.15 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
38,523,000
Free Float
N/A
Market Cap
$6.94 million
Optionable
No Data
Beta
2.05
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ONCE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners